Jonasson, Christian
Norwegian University of Science and Technology
7 papers on CoChatORCID 0000-0002-7694-6025
Most cited papers
- Verified
Plasma protein patterns as comprehensive indicators of health
Williams, S. A., Kivimaki, M., Langenberg, C., Hingorani, A. D., Casas, J. P., Bouchard, C., Jonasson, C., Sarzynski, M. A., Shipley, M. J., Alexander, L., et al. (2019) · Nature Medicine
Advanced Biosensing Techniques and ApplicationsHealth, Environment, Cognitive Aging
Cited by 506
- Verified
Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease
Ganz, P., Heidecker, B., Hveem, K., Jonasson, C., Kato, S., Segal, M. R., Sterling, D. G., & Williams, S. A. (2016) · JAMA
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 364
- Verified
Glucagon‐like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study
Pasternak, B., Wintzell, V., Hviid, A., Eliasson, B., Gudbjörnsdottir, S., Jonasson, C., Hveem, K., Svanström, H., Melbye, M., & Ueda, P. (2024) · BMJ
Diabetes Treatment and ManagementThyroid Cancer Diagnosis and Treatment
Cited by 125
- Verified
A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk
Williams, S. A., Ostroff, R., Hinterberg, M. A., Coresh, J., Ballantyne, C. M., Matsushita, K., Mueller, C. E., Walter, J., Jonasson, C., Holman, R. R., et al. (2022) · Science Translational Medicine
Lipoproteins and Cardiovascular HealthCardiovascular Health and Risk Factors
Cited by 97
- Verified
Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study
Engström, A., Wintzell, V., Melbye, M., Svanström, H., Eliasson, B., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Hviid, A., Ueda, P., et al. (2024) · Hepatology
Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment
Cited by 54
- Verified
Use of DPP4 Inhibitors and GLP-1 Receptor Agonists and Risk of Intestinal Obstruction: Scandinavian Cohort Study
Ueda, P., Wintzell, V., Melbye, M., Eliasson, B., Söderling, J., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Svanström, H., Hviid, A., et al. (2024) · Clinical Gastroenterology and Hepatology
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 34
- Verified
Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study
Ueda, P., Wintzell, V., Melbye, M., Eliasson, B., Svensson, A.-M., Franzén, S., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Svanström, H., et al. (2021) · Diabetologia
Cholangiocarcinoma and Gallbladder Cancer StudiesDiabetes Treatment and Management
Cited by 31
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free